E. Aguado, G. Mabilleau, E. Goyenvalle, and D. Chappard, Hypodynamia alters bone quality and trabecular microarchitecture, Calcif. Tissue Int, vol.100, issue.4, pp.332-340, 2017.
URL : https://hal.archives-ouvertes.fr/hal-02869270

P. Ammann, I. Badoud, S. Barraud, R. Dayer, and R. Rizzoli, Strontium ranelate treatment improves trabecular and cortical intrinsic bone tissue quality, a determinant of bone strength, J. Bone Miner. Res, vol.22, issue.9, pp.1419-1425, 2007.

H. Aoshima, K. Kushida, M. Takahashi, T. Ohishi, H. Hoshino et al., Circadian variation of urinary type I collagen crosslinked C-telopeptide and free and peptide-bound forms of pyridinium crosslinks, Bone, vol.22, issue.1, pp.73-78, 1998.

S. Aparicio, S. B. Doty, N. P. Camacho, E. P. Paschalis, L. Spevak et al., Optimal methods for processing mineralized tissues for Fourier transform infrared microspectroscopy, Calcif. Tissue Int, vol.70, issue.5, pp.422-429, 2002.

D. Bedell-hogan, P. Trackman, W. Abrams, J. Rosenbloom, and H. Kagan, Oxidation, cross-linking, and insolubilization of recombinant tropoelastin by purified lysyl oxidase, J. Biol. Chem, vol.268, issue.14, pp.10345-10350, 1993.

A. L. Boskey, Bone composition: relationship to bone fragility and antiosteoporotic drug effects, BoneKEy Rep, vol.2, p.447, 2013.

M. L. Bouxsein, S. K. Boyd, B. A. Christiansen, R. E. Guldberg, K. J. Jepsen et al., Guidelines for assessment of bone microstructure in rodents using microcomputed tomography, J. Bone Miner. Res, vol.25, issue.7, pp.1468-1486, 2010.

P. L. Brubaker, Glucagon-like peptide-2 and the regulation of intestinal growth and function, Compr. Physiol, vol.8, issue.3, pp.1185-1210, 2018.

D. Chappard, C. Alexandre, and G. Riffat, Histochemical identification of osteoclasts. Review of current methods and reappraisal of a simple procedure for routine diagnosis on undecalcified human iliac bone biopsies, Basic Appl. Histochem, vol.27, issue.2, pp.75-85, 1983.

D. Chappard, M. F. Basle, E. Legrand, and M. Audran, New laboratory tools in the assessment of bone quality, Osteoporos. Int, vol.22, issue.8, pp.2225-2240, 2011.
URL : https://hal.archives-ouvertes.fr/hal-00840072

, Consensus development conference: diagnosis, prophylaxis, and treatment of osteoporosis, Am. J. Med, vol.94, issue.6, pp.646-650

S. R. Cummings, J. San-martin, M. R. Mcclung, E. S. Siris, R. Eastell et al., Denosumab for prevention of fractures in postmenopausal women with osteoporosis, N. Engl. J. Med, vol.361, issue.8, pp.756-765, 2009.

D. W. Dempster, J. E. Compston, M. K. Drezner, F. H. Glorieux, J. A. Kanis et al., Standardized nomenclature, symbols, and units for bone histomorphometry: a 2012 update of the report of the ASBMR Histomorphometry Nomenclature Committee, J. Bone Miner. Res, vol.28, issue.1, pp.2-17, 2013.

D. J. Drucker, J. F. Habener, and J. J. Holst, Discovery, characterization, and clinical development of the glucagon-like peptides, J. Clin. Invest, vol.127, issue.12, pp.4217-4227, 2017.

J. L. Estall, B. Yusta, and D. J. Drucker, Lipid raft-dependent glucagon-like peptide-2 receptor trafficking occurs independently of agonist-induced desensitization, Mol. Biol. Cell, vol.15, issue.8, pp.3673-3687, 2004.

J. L. Estall, J. A. Koehler, B. Yusta, and D. J. Drucker, The glucagon-like peptide-2 receptor C terminus modulates beta-arrestin-2 association but is dispensable for ligand-induced desensitization, endocytosis, and G-protein-dependent effector activation, J. Biol. Chem, vol.280, issue.23, pp.22124-22134, 2005.

B. Ettinger, D. M. Black, B. H. Mitlak, R. K. Knickerbocker, T. Nickelsen et al., Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-year randomized clinical trial. Multiple Outcomes of Raloxifene Evaluation (MORE) Investigators, Jama, vol.282, issue.7, pp.637-645, 1999.

S. J. Gadaleta, E. P. Paschalis, F. Betts, R. Mendelsohn, and A. L. Boskey, Fourier transform infrared spectroscopy of the solution-mediated conversion of amorphous calcium phosphate to hydroxyapatite: new correlations between X-ray diffraction and infrared data, Calcif. Tissue Int, vol.58, issue.1, pp.9-16, 1996.

C. Gaudin-audrain, N. Irwin, S. Mansur, P. R. Flatt, B. Thorens et al., Glucose-dependent insulinotropic polypeptide receptor deficiency leads to modifications of trabecular bone volume and quality in mice, Bone, vol.53, issue.1, pp.221-230, 2013.

B. Hartmann, M. B. Harr, P. B. Jeppesen, M. Wojdemann, C. F. Deacon et al., In vivo and in vitro degradation of glucagon-like peptide-2 in humans, J. Clin. Endocrinol. Metab, vol.85, issue.8, pp.2884-2888, 2000.

D. B. Henriksen and J. J. Holst, Use of GLP-2 and related compounds for the treatment, prevention, diagnosis, and prognosis of bone-related disroders and calcium homeostasis related syndromes, vol.371, pp.721-723, 2008.

D. B. Henriksen, P. Alexandersen, N. H. Bjarnason, T. Vilsboll, B. Hartmann et al., Role of gastrointestinal hormones in postprandial reduction of bone resorption, J. Bone Miner. Res, vol.18, issue.12, pp.2180-2189, 2003.

D. B. Henriksen, P. Alexandersen, I. Byrjalsen, B. Hartmann, H. G. Bone et al., Reduction of nocturnal rise in bone resorption by subcutaneous GLP-2, Bone, vol.34, issue.1, pp.140-147, 2004.

D. B. Henriksen, P. Alexandersen, B. Hartmann, C. L. Adrian, I. Byrjalsen et al., Disassociation of bone resorption and formation by GLP-2: a 14-day study in healthy postmenopausal women, Bone, vol.40, issue.3, pp.723-729, 2007.

D. B. Henriksen, P. Alexandersen, B. Hartmann, C. L. Adrian, I. Byrjalsen et al., Four-month treatment with GLP-2 significantly increases hip BMD: a randomized, placebo-controlled, dose-ranging study in postmenopausal women with low BMD, Bone, vol.45, issue.5, pp.833-842, 2009.

H. M. Heshmati, B. L. Riggs, M. F. Burritt, C. A. Mcalister, P. C. Wollan et al., Effects of the circadian variation in serum cortisol on markers of bone turnover and calcium homeostasis in normal postmenopausal women, J. Clin. Endocrinol. Metab, vol.83, issue.3, pp.751-756, 1998.

P. B. Jeppesen, R. Gilroy, M. Pertkiewicz, J. P. Allard, B. Messing et al., Randomised placebo-controlled trial of teduglutide in reducing parenteral nutrition and/or intravenous fluid requirements in patients with short bowel syndrome, Gut, vol.60, issue.7, pp.902-914, 2011.

K. J. Jepsen, M. J. Silva, D. Vashishth, X. E. Guo, and M. C. Van-der-meulen, Establishing biomechanical mechanisms in mouse models: practical guidelines for systematically evaluating phenotypic changes in the diaphyses of long bones, J. Bone Miner. Res, vol.30, issue.6, pp.951-966, 2015.

S. Khosla, J. P. Bilezikian, D. W. Dempster, E. M. Lewiecki, P. D. Miller et al., Benefits and risks of bisphosphonate therapy for osteoporosis, J. Clin. Endocrinol. Metab, vol.97, issue.7, pp.2272-2282, 2012.

G. A. Ledger, M. F. Burritt, P. C. Kao, W. M. O'fallon, B. L. Riggs et al., Role of parathyroid hormone in mediating nocturnal and age-related increases in bone resorption, J. Clin. Endocrinol. Metab, vol.80, issue.11, pp.3304-3310, 1995.

G. H. Van-lenthe, R. Voide, S. K. Boyd, and R. Muller, Tissue modulus calculated from beam theory is biased by bone size and geometry: implications for the use of threepoint bending tests to determine bone tissue modulus, Bone, vol.43, issue.4, pp.717-723, 2008.

Y. Lu, D. Lu, and Y. Hu, Glucagon-like peptide 2 decreases osteoclasts by stimulating apoptosis dependent on nitric oxide synthase, Cell Prolif, vol.51, issue.4, p.12443, 2018.

G. Mabilleau, Interplay between bone and incretin hormones: a review, Morphologie, vol.101, issue.332, pp.9-18, 2017.
URL : https://hal.archives-ouvertes.fr/hal-02869275

G. Mabilleau, N. L. Petrova, M. E. Edmonds, and A. Sabokbar, Increased osteoclastic activity in acute Charcot's osteoarthropathy: the role of receptor activator of nuclear factor-kappaB ligand, Diabetologia, vol.51, issue.6, pp.1035-1040, 2008.

G. Mabilleau, A. Mieczkowska, N. Irwin, P. R. Flatt, and D. Chappard, Optimal bone mechanical and material properties require a functional glucagon-like peptide-1 receptor, J. Endocrinol, vol.219, issue.1, pp.59-68, 2013.

G. Mabilleau, A. Mieczkowska, N. Irwin, Y. Simon, M. Audran et al., Beneficial effects of a N-terminally modified GIP agonist on tissue-level bone material properties, Bone, vol.63, pp.61-68, 2014.

G. Mabilleau, A. Mieczkowska, H. Libouban, Y. Simon, M. Audran et al., Comparison between quantitative X-ray imaging, dual energy X-ray absorptiometry and microCT in the assessment of bone mineral density in disuse-induced bone loss, J. Musculoskelet. Neuronal Interact, vol.15, issue.1, pp.42-52, 2015.
URL : https://hal.archives-ouvertes.fr/hal-01396742

J. F. Marier, M. S. Mouksassi, N. H. Gosselin, M. Beliveau, J. Cyran et al., Population pharmacokinetics of teduglutide following repeated subcutaneous administrations in healthy participants and in patients with short bowel syndrome and Crohn's disease, J. Clin. Pharmacol, vol.50, issue.1, pp.36-49, 2010.

M. Mcclung, S. T. Harris, P. D. Miller, D. C. Bauer, K. S. Davison et al., Bisphosphonate therapy for osteoporosis: benefits, risks, and drug holiday, Am. J. Med, vol.126, issue.1, pp.13-20, 2013.

A. Mieczkowska, N. Irwin, P. R. Flatt, D. Chappard, and G. Mabilleau, Glucose-dependent insulinotropic polypeptide (GIP) receptor deletion leads to reduced bone strength and quality, Bone, vol.56, issue.2, pp.337-342, 2013.

A. Mieczkowska, B. Bouvard, D. Chappard, and G. Mabilleau, Glucose-dependent insulinotropic polypeptide (GIP) directly affects collagen fibril diameter and collagen cross-linking in osteoblast cultures, Bone, vol.74, pp.29-36, 2015.
URL : https://hal.archives-ouvertes.fr/hal-01392274

R. M. Neer, C. D. Arnaud, J. R. Zanchetta, R. Prince, G. A. Gaich et al., Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis, N. Engl. J. Med, vol.344, pp.1434-1441, 2001.

Z. Ostrowska, B. Kos-kudla, B. Marek, E. Swietochowska, and J. Gorski, Assessment of the relationship between circadian variations of salivary melatonin levels and type I collagen metabolism in postmenopausal obese women, Neuro Endocrinol. Lett, vol.22, issue.2, pp.121-127, 2001.

H. Ou-yang, E. P. Paschalis, W. E. Mayo, A. L. Boskey, and R. Mendelsohn, Infrared microscopic imaging of bone: spatial distribution of CO3(2-), J. Bone Miner. Res, vol.16, issue.5, pp.893-900, 2001.

E. P. Paschalis, K. Verdelis, S. B. Doty, A. L. Boskey, R. Mendelsohn et al., Spectroscopic characterization of collagen cross-links in bone, J. Bone Miner. Res, vol.16, issue.10, pp.1821-1828, 2001.

E. P. Paschalis, S. Gamsjaeger, D. N. Tatakis, N. Hassler, S. P. Robins et al., Fourier transform infrared spectroscopic characterization of mineralizing type I collagen enzymatic trivalent cross-links, Calcif. Tissue Int, vol.96, issue.1, pp.18-29, 2015.

R. R. Recker, D. B. Kimmel, D. Dempster, R. S. Weinstein, T. J. Wronski et al., Issues in modern bone histomorphometry, Bone, vol.49, issue.5, pp.955-964, 2011.

P. Roschger, P. Fratzl, J. Eschberger, and K. Klaushofer, Validation of quantitative backscattered electron imaging for the measurement of mineral density distribution in human bone biopsies, Bone, vol.23, issue.4, pp.319-326, 1998.

A. Schlemmer and C. Hassager, Acute fasting diminishes the circadian rhythm of biochemical markers of bone resorption, Eur. J. Endocrinol, vol.140, issue.4, pp.332-337, 1999.

A. Schlemmer, C. Hassager, B. J. Pedersen, and C. Christiansen, Posture, age, menopause, and osteopenia do not influence the circadian variation in the urinary excretion of pyridinium crosslinks, J. Bone Miner. Res, vol.9, issue.12, pp.1883-1888, 1994.

T. Starborg, N. S. Kalson, Y. Lu, A. Mironov, T. F. Cootes et al., Using transmission electron microscopy and 3View to determine collagen fibril size and three-dimensional organization, Nat. Protoc, vol.8, issue.7, pp.1433-1448, 2013.

C. H. Turner and D. B. Burr, Basic biomechanical measurements of bone: a tutorial, Bone, vol.14, issue.4, pp.595-608, 1993.

A. H. Undale, D. J. Drucker, U. I. Moedder, M. J. Pursler, D. G. Fraser et al., Deletion of glucagon-like peptide-2 receptor leads to marked skeletal deficits in growing mice, 28th Annual Meeting of the American Society of Bone and Mineral Research (ASBMR), 2006.

D. Vashishth, Small animal bone biomechanics, Bone, vol.43, issue.5, pp.794-797, 2008.

M. Wichers, E. Schmidt, F. Bidlingmaier, and D. Klingmuller, Diurnal rhythm of CrossLaps in human serum, Clin. Chem, vol.45, issue.10, pp.1858-1860, 1999.

B. Xu, Y. He, Y. Lu, W. Ren, J. Shen et al., Glucagon like peptide 2 has a positive impact on osteoporosis in ovariectomized rats, Life Sci, vol.226, pp.47-56, 2019.